nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—Benazepril—Lisinopril—systemic scleroderma	0.423	1	CrCrCtD
Imipramine—CYP1A2—Pentoxifylline—systemic scleroderma	0.0377	0.159	CbGbCtD
Imipramine—CYP1A2—Leflunomide—systemic scleroderma	0.036	0.151	CbGbCtD
Imipramine—ABCB1—Lisinopril—systemic scleroderma	0.033	0.139	CbGbCtD
Imipramine—ABCB1—Captopril—systemic scleroderma	0.0247	0.104	CbGbCtD
Imipramine—CYP2D6—Captopril—systemic scleroderma	0.0233	0.0979	CbGbCtD
Imipramine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0194	0.0818	CbGbCtD
Imipramine—CYP2C19—Prednisone—systemic scleroderma	0.0193	0.081	CbGbCtD
Imipramine—ABCB1—Prednisone—systemic scleroderma	0.0155	0.0654	CbGbCtD
Imipramine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0116	0.049	CbGbCtD
Imipramine—CYP3A4—Prednisone—systemic scleroderma	0.00931	0.0392	CbGbCtD
Imipramine—HTR7—myenteric nerve plexus—systemic scleroderma	0.00781	0.132	CbGeAlD
Imipramine—ABCB1—Methotrexate—systemic scleroderma	0.00779	0.0328	CbGbCtD
Imipramine—HTR7—pulmonary artery—systemic scleroderma	0.00553	0.0936	CbGeAlD
Imipramine—HTR2A—myenteric nerve plexus—systemic scleroderma	0.00487	0.0824	CbGeAlD
Imipramine—HTR2A—pulmonary artery—systemic scleroderma	0.00345	0.0583	CbGeAlD
Imipramine—HTR7—artery—systemic scleroderma	0.00205	0.0347	CbGeAlD
Imipramine—HTR7—endothelium—systemic scleroderma	0.00173	0.0293	CbGeAlD
Imipramine—HTR7—blood vessel—systemic scleroderma	0.0016	0.027	CbGeAlD
Imipramine—CHRM5—skin of body—systemic scleroderma	0.00139	0.0235	CbGeAlD
Imipramine—CYP2C18—digestive system—systemic scleroderma	0.00136	0.023	CbGeAlD
Imipramine—HTR2A—artery—systemic scleroderma	0.00128	0.0216	CbGeAlD
Imipramine—KCND3—lung—systemic scleroderma	0.00125	0.0211	CbGeAlD
Imipramine—HTR2A—endothelium—systemic scleroderma	0.00108	0.0183	CbGeAlD
Imipramine—SLC22A2—digestive system—systemic scleroderma	0.00106	0.0179	CbGeAlD
Imipramine—HTR2A—blood vessel—systemic scleroderma	0.000996	0.0168	CbGeAlD
Imipramine—SLC22A3—connective tissue—systemic scleroderma	0.000992	0.0168	CbGeAlD
Imipramine—SLC22A3—smooth muscle tissue—systemic scleroderma	0.000907	0.0153	CbGeAlD
Imipramine—HTR7—connective tissue—systemic scleroderma	0.000819	0.0139	CbGeAlD
Imipramine—CHRM3—smooth muscle tissue—systemic scleroderma	0.000787	0.0133	CbGeAlD
Imipramine—SLC22A4—digestive system—systemic scleroderma	0.000787	0.0133	CbGeAlD
Imipramine—HTR7—smooth muscle tissue—systemic scleroderma	0.000749	0.0127	CbGeAlD
Imipramine—SLC22A4—tendon—systemic scleroderma	0.000749	0.0127	CbGeAlD
Imipramine—SLC6A4—digestive system—systemic scleroderma	0.000697	0.0118	CbGeAlD
Imipramine—ORM1—lung—systemic scleroderma	0.000683	0.0116	CbGeAlD
Imipramine—SLC22A4—lung—systemic scleroderma	0.000657	0.0111	CbGeAlD
Imipramine—ABCB1—blood vessel—systemic scleroderma	0.000653	0.011	CbGeAlD
Imipramine—SLC6A3—lung—systemic scleroderma	0.000635	0.0107	CbGeAlD
Imipramine—CHRM3—digestive system—systemic scleroderma	0.000622	0.0105	CbGeAlD
Imipramine—HRH1—connective tissue—systemic scleroderma	0.000612	0.0103	CbGeAlD
Imipramine—SLC22A3—lung—systemic scleroderma	0.000598	0.0101	CbGeAlD
Imipramine—HTR7—digestive system—systemic scleroderma	0.000592	0.01	CbGeAlD
Imipramine—SLC6A4—lung—systemic scleroderma	0.000582	0.00985	CbGeAlD
Imipramine—CHRM1—lung—systemic scleroderma	0.00058	0.00981	CbGeAlD
Imipramine—CYP2C19—digestive system—systemic scleroderma	0.000578	0.00977	CbGeAlD
Imipramine—CYP2B6—skin of body—systemic scleroderma	0.000566	0.00956	CbGeAlD
Imipramine—HTR7—tendon—systemic scleroderma	0.000563	0.00952	CbGeAlD
Imipramine—HRH1—smooth muscle tissue—systemic scleroderma	0.00056	0.00946	CbGeAlD
Imipramine—SLC6A2—lung—systemic scleroderma	0.000513	0.00867	CbGeAlD
Imipramine—HTR2A—connective tissue—systemic scleroderma	0.000511	0.00864	CbGeAlD
Imipramine—HTR7—lung—systemic scleroderma	0.000494	0.00836	CbGeAlD
Imipramine—CYP1A2—digestive system—systemic scleroderma	0.000472	0.00798	CbGeAlD
Imipramine—HTR2A—smooth muscle tissue—systemic scleroderma	0.000467	0.0079	CbGeAlD
Imipramine—DRD2—lung—systemic scleroderma	0.000467	0.0079	CbGeAlD
Imipramine—CYP2B6—digestive system—systemic scleroderma	0.000452	0.00765	CbGeAlD
Imipramine—HRH1—digestive system—systemic scleroderma	0.000442	0.00747	CbGeAlD
Imipramine—CYP2E1—digestive system—systemic scleroderma	0.000425	0.00718	CbGeAlD
Imipramine—HRH1—tendon—systemic scleroderma	0.00042	0.00711	CbGeAlD
Imipramine—CYP2E1—tendon—systemic scleroderma	0.000404	0.00683	CbGeAlD
Imipramine—CYP1A2—lung—systemic scleroderma	0.000394	0.00666	CbGeAlD
Imipramine—CYP2B6—lung—systemic scleroderma	0.000378	0.00639	CbGeAlD
Imipramine—HTR2A—digestive system—systemic scleroderma	0.000369	0.00624	CbGeAlD
Imipramine—HRH1—lung—systemic scleroderma	0.000369	0.00624	CbGeAlD
Imipramine—CYP2E1—lung—systemic scleroderma	0.000355	0.006	CbGeAlD
Imipramine—HTR2A—tendon—systemic scleroderma	0.000351	0.00594	CbGeAlD
Imipramine—CYP3A4—digestive system—systemic scleroderma	0.000342	0.00578	CbGeAlD
Imipramine—CYP2D6—digestive system—systemic scleroderma	0.000336	0.00568	CbGeAlD
Imipramine—HTR2A—lung—systemic scleroderma	0.000308	0.00521	CbGeAlD
Imipramine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000298	0.00106	CcSEcCtD
Imipramine—Insomnia—Mycophenolic acid—systemic scleroderma	0.000298	0.00106	CcSEcCtD
Imipramine—Fatigue—Leflunomide—systemic scleroderma	0.000298	0.00106	CcSEcCtD
Imipramine—Oedema—Lisinopril—systemic scleroderma	0.000297	0.00106	CcSEcCtD
Imipramine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000297	0.00106	CcSEcCtD
Imipramine—Pruritus—Captopril—systemic scleroderma	0.000296	0.00106	CcSEcCtD
Imipramine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000296	0.00106	CcSEcCtD
Imipramine—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000296	0.00106	CcSEcCtD
Imipramine—Constipation—Leflunomide—systemic scleroderma	0.000295	0.00105	CcSEcCtD
Imipramine—Infection—Lisinopril—systemic scleroderma	0.000295	0.00105	CcSEcCtD
Imipramine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000293	0.00105	CcSEcCtD
Imipramine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000293	0.00105	CcSEcCtD
Imipramine—Shock—Lisinopril—systemic scleroderma	0.000292	0.00104	CcSEcCtD
Imipramine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000291	0.00104	CcSEcCtD
Imipramine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00029	0.00104	CcSEcCtD
Imipramine—Tachycardia—Lisinopril—systemic scleroderma	0.00029	0.00103	CcSEcCtD
Imipramine—Abdominal pain—Azathioprine—systemic scleroderma	0.000289	0.00103	CcSEcCtD
Imipramine—Body temperature increased—Azathioprine—systemic scleroderma	0.000289	0.00103	CcSEcCtD
Imipramine—Skin disorder—Lisinopril—systemic scleroderma	0.000288	0.00103	CcSEcCtD
Imipramine—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000287	0.00103	CcSEcCtD
Imipramine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000287	0.00102	CcSEcCtD
Imipramine—Diarrhoea—Captopril—systemic scleroderma	0.000287	0.00102	CcSEcCtD
Imipramine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000286	0.00102	CcSEcCtD
Imipramine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000286	0.00102	CcSEcCtD
Imipramine—Erectile dysfunction—Prednisone—systemic scleroderma	0.000285	0.00102	CcSEcCtD
Imipramine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000285	0.00102	CcSEcCtD
Imipramine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000285	0.00102	CcSEcCtD
Imipramine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000284	0.00102	CcSEcCtD
Imipramine—Fatigue—Mycophenolic acid—systemic scleroderma	0.000284	0.00101	CcSEcCtD
Imipramine—Mood swings—Methotrexate—systemic scleroderma	0.000284	0.00101	CcSEcCtD
Imipramine—Nausea—Mometasone—systemic scleroderma	0.000283	0.00101	CcSEcCtD
Imipramine—Anorexia—Lisinopril—systemic scleroderma	0.000283	0.00101	CcSEcCtD
Imipramine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000282	0.00101	CcSEcCtD
Imipramine—Weight increased—Prednisone—systemic scleroderma	0.000282	0.00101	CcSEcCtD
Imipramine—Ataxia—Methotrexate—systemic scleroderma	0.000282	0.00101	CcSEcCtD
Imipramine—Constipation—Mycophenolic acid—systemic scleroderma	0.000282	0.00101	CcSEcCtD
Imipramine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000282	0.001	CcSEcCtD
Imipramine—Weight decreased—Prednisone—systemic scleroderma	0.00028	0.001	CcSEcCtD
Imipramine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00028	0.001	CcSEcCtD
Imipramine—Dizziness—Captopril—systemic scleroderma	0.000277	0.000989	CcSEcCtD
Imipramine—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000277	0.000988	CcSEcCtD
Imipramine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000276	0.000985	CcSEcCtD
Imipramine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000275	0.000982	CcSEcCtD
Imipramine—Urticaria—Leflunomide—systemic scleroderma	0.000274	0.000979	CcSEcCtD
Imipramine—Abdominal pain—Leflunomide—systemic scleroderma	0.000273	0.000975	CcSEcCtD
Imipramine—Body temperature increased—Leflunomide—systemic scleroderma	0.000273	0.000975	CcSEcCtD
Imipramine—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000272	0.000972	CcSEcCtD
Imipramine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000272	0.000969	CcSEcCtD
Imipramine—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000271	0.000967	CcSEcCtD
Imipramine—Myocardial infarction—Prednisone—systemic scleroderma	0.000271	0.000967	CcSEcCtD
Imipramine—Breast disorder—Methotrexate—systemic scleroderma	0.000271	0.000967	CcSEcCtD
Imipramine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00027	0.000965	CcSEcCtD
Imipramine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000269	0.000962	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000269	0.000961	CcSEcCtD
Imipramine—Insomnia—Lisinopril—systemic scleroderma	0.000268	0.000958	CcSEcCtD
Imipramine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000268	0.000957	CcSEcCtD
Imipramine—Paraesthesia—Lisinopril—systemic scleroderma	0.000266	0.000951	CcSEcCtD
Imipramine—Vomiting—Captopril—systemic scleroderma	0.000266	0.000951	CcSEcCtD
Imipramine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000265	0.000947	CcSEcCtD
Imipramine—Rash—Captopril—systemic scleroderma	0.000264	0.000943	CcSEcCtD
Imipramine—Dermatitis—Captopril—systemic scleroderma	0.000264	0.000942	CcSEcCtD
Imipramine—Somnolence—Lisinopril—systemic scleroderma	0.000264	0.000942	CcSEcCtD
Imipramine—Headache—Captopril—systemic scleroderma	0.000263	0.000937	CcSEcCtD
Imipramine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000262	0.000936	CcSEcCtD
Imipramine—Dyspepsia—Lisinopril—systemic scleroderma	0.000261	0.000932	CcSEcCtD
Imipramine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00026	0.00093	CcSEcCtD
Imipramine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00026	0.00093	CcSEcCtD
Imipramine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00026	0.000928	CcSEcCtD
Imipramine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00026	0.000928	CcSEcCtD
Imipramine—Infection—Mycophenolate mofetil—systemic scleroderma	0.000258	0.000922	CcSEcCtD
Imipramine—Decreased appetite—Lisinopril—systemic scleroderma	0.000258	0.000921	CcSEcCtD
Imipramine—Eosinophilia—Methotrexate—systemic scleroderma	0.000256	0.000915	CcSEcCtD
Imipramine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000256	0.000915	CcSEcCtD
Imipramine—Fatigue—Lisinopril—systemic scleroderma	0.000256	0.000913	CcSEcCtD
Imipramine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000256	0.000913	CcSEcCtD
Imipramine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000255	0.00091	CcSEcCtD
Imipramine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000255	0.000909	CcSEcCtD
Imipramine—Constipation—Lisinopril—systemic scleroderma	0.000254	0.000906	CcSEcCtD
Imipramine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000254	0.000906	CcSEcCtD
Imipramine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000253	0.000901	CcSEcCtD
Imipramine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000251	0.000897	CcSEcCtD
Imipramine—Diarrhoea—Azathioprine—systemic scleroderma	0.00025	0.000893	CcSEcCtD
Imipramine—Nausea—Captopril—systemic scleroderma	0.000249	0.000888	CcSEcCtD
Imipramine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000248	0.000885	CcSEcCtD
Imipramine—Asthenia—Leflunomide—systemic scleroderma	0.000248	0.000884	CcSEcCtD
Imipramine—Hallucination—Prednisone—systemic scleroderma	0.000247	0.000881	CcSEcCtD
Imipramine—Pancytopenia—Methotrexate—systemic scleroderma	0.000246	0.000878	CcSEcCtD
Imipramine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000245	0.000873	CcSEcCtD
Imipramine—Pruritus—Leflunomide—systemic scleroderma	0.000244	0.000872	CcSEcCtD
Imipramine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000243	0.000866	CcSEcCtD
Imipramine—Dizziness—Azathioprine—systemic scleroderma	0.000242	0.000863	CcSEcCtD
Imipramine—ABCB1—digestive system—systemic scleroderma	0.000242	0.00409	CbGeAlD
Imipramine—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000239	0.000852	CcSEcCtD
Imipramine—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000236	0.000844	CcSEcCtD
Imipramine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000236	0.000844	CcSEcCtD
Imipramine—Diarrhoea—Leflunomide—systemic scleroderma	0.000236	0.000843	CcSEcCtD
Imipramine—Urticaria—Lisinopril—systemic scleroderma	0.000236	0.000842	CcSEcCtD
Imipramine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000235	0.000839	CcSEcCtD
Imipramine—Abdominal pain—Lisinopril—systemic scleroderma	0.000235	0.000837	CcSEcCtD
Imipramine—Body temperature increased—Lisinopril—systemic scleroderma	0.000235	0.000837	CcSEcCtD
Imipramine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000233	0.000833	CcSEcCtD
Imipramine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000233	0.000832	CcSEcCtD
Imipramine—Vomiting—Azathioprine—systemic scleroderma	0.000233	0.00083	CcSEcCtD
Imipramine—Eye disorder—Prednisone—systemic scleroderma	0.000232	0.000828	CcSEcCtD
Imipramine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000231	0.000825	CcSEcCtD
Imipramine—Infestation NOS—Methotrexate—systemic scleroderma	0.000231	0.000824	CcSEcCtD
Imipramine—Drowsiness—Methotrexate—systemic scleroderma	0.000231	0.000824	CcSEcCtD
Imipramine—Infestation—Methotrexate—systemic scleroderma	0.000231	0.000824	CcSEcCtD
Imipramine—Rash—Azathioprine—systemic scleroderma	0.000231	0.000823	CcSEcCtD
Imipramine—Dermatitis—Azathioprine—systemic scleroderma	0.00023	0.000822	CcSEcCtD
Imipramine—Flushing—Prednisone—systemic scleroderma	0.00023	0.000822	CcSEcCtD
Imipramine—Headache—Azathioprine—systemic scleroderma	0.000229	0.000818	CcSEcCtD
Imipramine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000229	0.000817	CcSEcCtD
Imipramine—Dizziness—Leflunomide—systemic scleroderma	0.000228	0.000815	CcSEcCtD
Imipramine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000226	0.000807	CcSEcCtD
Imipramine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000225	0.000805	CcSEcCtD
Imipramine—Stomatitis—Methotrexate—systemic scleroderma	0.000225	0.000804	CcSEcCtD
Imipramine—Angiopathy—Prednisone—systemic scleroderma	0.000225	0.000803	CcSEcCtD
Imipramine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000224	0.000801	CcSEcCtD
Imipramine—Immune system disorder—Prednisone—systemic scleroderma	0.000224	0.0008	CcSEcCtD
Imipramine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000222	0.000794	CcSEcCtD
Imipramine—Arrhythmia—Prednisone—systemic scleroderma	0.000222	0.000791	CcSEcCtD
Imipramine—Vomiting—Leflunomide—systemic scleroderma	0.00022	0.000784	CcSEcCtD
Imipramine—Alopecia—Prednisone—systemic scleroderma	0.000219	0.000782	CcSEcCtD
Imipramine—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000218	0.00078	CcSEcCtD
Imipramine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000218	0.000778	CcSEcCtD
Imipramine—Rash—Leflunomide—systemic scleroderma	0.000218	0.000777	CcSEcCtD
Imipramine—Dermatitis—Leflunomide—systemic scleroderma	0.000218	0.000777	CcSEcCtD
Imipramine—Mental disorder—Prednisone—systemic scleroderma	0.000217	0.000776	CcSEcCtD
Imipramine—Nausea—Azathioprine—systemic scleroderma	0.000217	0.000775	CcSEcCtD
Imipramine—Headache—Leflunomide—systemic scleroderma	0.000216	0.000772	CcSEcCtD
Imipramine—Malnutrition—Prednisone—systemic scleroderma	0.000216	0.000771	CcSEcCtD
Imipramine—Agranulocytosis—Methotrexate—systemic scleroderma	0.000216	0.000769	CcSEcCtD
Imipramine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000214	0.000765	CcSEcCtD
Imipramine—Asthenia—Lisinopril—systemic scleroderma	0.000213	0.00076	CcSEcCtD
Imipramine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000213	0.000759	CcSEcCtD
Imipramine—Pruritus—Lisinopril—systemic scleroderma	0.00021	0.000749	CcSEcCtD
Imipramine—Vomiting—Mycophenolic acid—systemic scleroderma	0.00021	0.000748	CcSEcCtD
Imipramine—Rash—Mycophenolic acid—systemic scleroderma	0.000208	0.000742	CcSEcCtD
Imipramine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000208	0.000741	CcSEcCtD
Imipramine—Hepatitis—Methotrexate—systemic scleroderma	0.000207	0.00074	CcSEcCtD
Imipramine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000207	0.000737	CcSEcCtD
Imipramine—Headache—Mycophenolic acid—systemic scleroderma	0.000206	0.000737	CcSEcCtD
Imipramine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000206	0.000734	CcSEcCtD
Imipramine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000206	0.000734	CcSEcCtD
Imipramine—Nausea—Leflunomide—systemic scleroderma	0.000205	0.000732	CcSEcCtD
Imipramine—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000205	0.000731	CcSEcCtD
Imipramine—Vision blurred—Prednisone—systemic scleroderma	0.000204	0.000726	CcSEcCtD
Imipramine—Urethral disorder—Methotrexate—systemic scleroderma	0.000203	0.000725	CcSEcCtD
Imipramine—Diarrhoea—Lisinopril—systemic scleroderma	0.000203	0.000725	CcSEcCtD
Imipramine—ABCB1—lung—systemic scleroderma	0.000202	0.00341	CbGeAlD
Imipramine—Ill-defined disorder—Prednisone—systemic scleroderma	0.0002	0.000715	CcSEcCtD
Imipramine—Agitation—Prednisone—systemic scleroderma	0.000198	0.000708	CcSEcCtD
Imipramine—Dizziness—Lisinopril—systemic scleroderma	0.000196	0.0007	CcSEcCtD
Imipramine—Nausea—Mycophenolic acid—systemic scleroderma	0.000196	0.000699	CcSEcCtD
Imipramine—Malaise—Prednisone—systemic scleroderma	0.000195	0.000695	CcSEcCtD
Imipramine—Eye disorder—Methotrexate—systemic scleroderma	0.000194	0.000692	CcSEcCtD
Imipramine—Syncope—Prednisone—systemic scleroderma	0.000194	0.000691	CcSEcCtD
Imipramine—Tinnitus—Methotrexate—systemic scleroderma	0.000193	0.00069	CcSEcCtD
Imipramine—Cardiac disorder—Methotrexate—systemic scleroderma	0.000192	0.000687	CcSEcCtD
Imipramine—Loss of consciousness—Prednisone—systemic scleroderma	0.00019	0.000678	CcSEcCtD
Imipramine—Vomiting—Lisinopril—systemic scleroderma	0.000189	0.000674	CcSEcCtD
Imipramine—Angiopathy—Methotrexate—systemic scleroderma	0.000188	0.000671	CcSEcCtD
Imipramine—Immune system disorder—Methotrexate—systemic scleroderma	0.000187	0.000668	CcSEcCtD
Imipramine—Rash—Lisinopril—systemic scleroderma	0.000187	0.000668	CcSEcCtD
Imipramine—Convulsion—Prednisone—systemic scleroderma	0.000187	0.000668	CcSEcCtD
Imipramine—Dermatitis—Lisinopril—systemic scleroderma	0.000187	0.000667	CcSEcCtD
Imipramine—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000187	0.000667	CcSEcCtD
Imipramine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000187	0.000666	CcSEcCtD
Imipramine—Hypertension—Prednisone—systemic scleroderma	0.000186	0.000666	CcSEcCtD
Imipramine—Headache—Lisinopril—systemic scleroderma	0.000186	0.000664	CcSEcCtD
Imipramine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000184	0.000657	CcSEcCtD
Imipramine—Anxiety—Prednisone—systemic scleroderma	0.000183	0.000654	CcSEcCtD
Imipramine—Alopecia—Methotrexate—systemic scleroderma	0.000183	0.000654	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000183	0.000652	CcSEcCtD
Imipramine—Discomfort—Prednisone—systemic scleroderma	0.000182	0.000648	CcSEcCtD
Imipramine—Mental disorder—Methotrexate—systemic scleroderma	0.000182	0.000648	CcSEcCtD
Imipramine—Malnutrition—Methotrexate—systemic scleroderma	0.00018	0.000644	CcSEcCtD
Imipramine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000178	0.000635	CcSEcCtD
Imipramine—Dysgeusia—Methotrexate—systemic scleroderma	0.000177	0.000631	CcSEcCtD
Imipramine—Nausea—Lisinopril—systemic scleroderma	0.000176	0.000629	CcSEcCtD
Imipramine—Anaphylactic shock—Prednisone—systemic scleroderma	0.000176	0.000629	CcSEcCtD
Imipramine—Oedema—Prednisone—systemic scleroderma	0.000176	0.000629	CcSEcCtD
Imipramine—Infection—Prednisone—systemic scleroderma	0.000175	0.000625	CcSEcCtD
Imipramine—Shock—Prednisone—systemic scleroderma	0.000173	0.000619	CcSEcCtD
Imipramine—Nervous system disorder—Prednisone—systemic scleroderma	0.000173	0.000617	CcSEcCtD
Imipramine—Tachycardia—Prednisone—systemic scleroderma	0.000172	0.000614	CcSEcCtD
Imipramine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000172	0.000614	CcSEcCtD
Imipramine—Skin disorder—Prednisone—systemic scleroderma	0.000171	0.000611	CcSEcCtD
Imipramine—Hyperhidrosis—Prednisone—systemic scleroderma	0.00017	0.000608	CcSEcCtD
Imipramine—Vision blurred—Methotrexate—systemic scleroderma	0.00017	0.000607	CcSEcCtD
Imipramine—Anorexia—Prednisone—systemic scleroderma	0.000168	0.0006	CcSEcCtD
Imipramine—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000167	0.000598	CcSEcCtD
Imipramine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000165	0.00059	CcSEcCtD
Imipramine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000164	0.000585	CcSEcCtD
Imipramine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000164	0.000585	CcSEcCtD
Imipramine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000163	0.000581	CcSEcCtD
Imipramine—Malaise—Methotrexate—systemic scleroderma	0.000163	0.000581	CcSEcCtD
Imipramine—Leukopenia—Methotrexate—systemic scleroderma	0.000162	0.000577	CcSEcCtD
Imipramine—Insomnia—Prednisone—systemic scleroderma	0.000159	0.000569	CcSEcCtD
Imipramine—Paraesthesia—Prednisone—systemic scleroderma	0.000158	0.000565	CcSEcCtD
Imipramine—Convulsion—Methotrexate—systemic scleroderma	0.000156	0.000558	CcSEcCtD
Imipramine—Dyspepsia—Prednisone—systemic scleroderma	0.000155	0.000554	CcSEcCtD
Imipramine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000154	0.000551	CcSEcCtD
Imipramine—Decreased appetite—Prednisone—systemic scleroderma	0.000153	0.000547	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000153	0.000545	CcSEcCtD
Imipramine—Fatigue—Prednisone—systemic scleroderma	0.000152	0.000542	CcSEcCtD
Imipramine—Discomfort—Methotrexate—systemic scleroderma	0.000152	0.000542	CcSEcCtD
Imipramine—Constipation—Prednisone—systemic scleroderma	0.000151	0.000538	CcSEcCtD
Imipramine—Confusional state—Methotrexate—systemic scleroderma	0.000149	0.00053	CcSEcCtD
Imipramine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000147	0.000526	CcSEcCtD
Imipramine—Infection—Methotrexate—systemic scleroderma	0.000146	0.000522	CcSEcCtD
Imipramine—Feeling abnormal—Prednisone—systemic scleroderma	0.000145	0.000518	CcSEcCtD
Imipramine—Nervous system disorder—Methotrexate—systemic scleroderma	0.000144	0.000516	CcSEcCtD
Imipramine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000144	0.000515	CcSEcCtD
Imipramine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000144	0.000514	CcSEcCtD
Imipramine—Skin disorder—Methotrexate—systemic scleroderma	0.000143	0.000511	CcSEcCtD
Imipramine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000142	0.000508	CcSEcCtD
Imipramine—Anorexia—Methotrexate—systemic scleroderma	0.00014	0.000501	CcSEcCtD
Imipramine—Urticaria—Prednisone—systemic scleroderma	0.00014	0.0005	CcSEcCtD
Imipramine—Abdominal pain—Prednisone—systemic scleroderma	0.000139	0.000497	CcSEcCtD
Imipramine—Body temperature increased—Prednisone—systemic scleroderma	0.000139	0.000497	CcSEcCtD
Imipramine—Insomnia—Methotrexate—systemic scleroderma	0.000133	0.000476	CcSEcCtD
Imipramine—Paraesthesia—Methotrexate—systemic scleroderma	0.000132	0.000472	CcSEcCtD
Imipramine—Somnolence—Methotrexate—systemic scleroderma	0.000131	0.000467	CcSEcCtD
Imipramine—Dyspepsia—Methotrexate—systemic scleroderma	0.00013	0.000463	CcSEcCtD
Imipramine—Decreased appetite—Methotrexate—systemic scleroderma	0.000128	0.000457	CcSEcCtD
Imipramine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000127	0.000454	CcSEcCtD
Imipramine—Fatigue—Methotrexate—systemic scleroderma	0.000127	0.000453	CcSEcCtD
Imipramine—Asthenia—Prednisone—systemic scleroderma	0.000126	0.000451	CcSEcCtD
Imipramine—Pruritus—Prednisone—systemic scleroderma	0.000125	0.000445	CcSEcCtD
Imipramine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000121	0.000433	CcSEcCtD
Imipramine—Diarrhoea—Prednisone—systemic scleroderma	0.000121	0.00043	CcSEcCtD
Imipramine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00012	0.00043	CcSEcCtD
Imipramine—Urticaria—Methotrexate—systemic scleroderma	0.000117	0.000418	CcSEcCtD
Imipramine—Dizziness—Prednisone—systemic scleroderma	0.000117	0.000416	CcSEcCtD
Imipramine—Abdominal pain—Methotrexate—systemic scleroderma	0.000116	0.000416	CcSEcCtD
Imipramine—Body temperature increased—Methotrexate—systemic scleroderma	0.000116	0.000416	CcSEcCtD
Imipramine—Vomiting—Prednisone—systemic scleroderma	0.000112	0.0004	CcSEcCtD
Imipramine—Rash—Prednisone—systemic scleroderma	0.000111	0.000397	CcSEcCtD
Imipramine—Dermatitis—Prednisone—systemic scleroderma	0.000111	0.000396	CcSEcCtD
Imipramine—Headache—Prednisone—systemic scleroderma	0.00011	0.000394	CcSEcCtD
Imipramine—Asthenia—Methotrexate—systemic scleroderma	0.000106	0.000377	CcSEcCtD
Imipramine—Nausea—Prednisone—systemic scleroderma	0.000105	0.000374	CcSEcCtD
Imipramine—Pruritus—Methotrexate—systemic scleroderma	0.000104	0.000372	CcSEcCtD
Imipramine—Diarrhoea—Methotrexate—systemic scleroderma	0.000101	0.00036	CcSEcCtD
Imipramine—Dizziness—Methotrexate—systemic scleroderma	9.74e-05	0.000348	CcSEcCtD
Imipramine—Vomiting—Methotrexate—systemic scleroderma	9.37e-05	0.000334	CcSEcCtD
Imipramine—Rash—Methotrexate—systemic scleroderma	9.29e-05	0.000332	CcSEcCtD
Imipramine—Dermatitis—Methotrexate—systemic scleroderma	9.28e-05	0.000331	CcSEcCtD
Imipramine—Headache—Methotrexate—systemic scleroderma	9.23e-05	0.000329	CcSEcCtD
Imipramine—Nausea—Methotrexate—systemic scleroderma	8.75e-05	0.000312	CcSEcCtD
Imipramine—Benazepril—ACE—systemic scleroderma	6.84e-05	1	CrCbGaD
